mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Exosomes in liquid biopsy: a nanometric particle packed with potential
Katie Dale - March 14, 2022

Exosomes in liquid biopsy: a nanometric particle packed with potential

We are all too familiar with the statistic that 1 in 2 of us will get cancer in our lifetime. Of ...

Predicting the unpredictable during pregnancy
Frances Salisbury - February 10, 2022

Predicting the unpredictable during pregnancy

For many expectant parents, pregnancy is a time of excitement, yet this time can also be riddled ...

Capturing the DNA hydroxymethylome for early-stage cancer detection
Jane Liu - October 21, 2021

Capturing the DNA hydroxymethylome for early-stage cancer detection

Biomarkers are measurable indicators of health or disease and the detection of biomarkers in liquid ...

Circulating tumour cells: at the forefront of cancer diagnosis and treatment
Samuel Hart - June 30, 2021

Circulating tumour cells: at the forefront of cancer diagnosis and treatment

In cancer patients, “metastasis” occurs as tumour cells break-away from the site at which they are ...

Cancer diagnosis – new data to support methylation-based liquid biopsy
Thomas Driver - June 30, 2021

Cancer diagnosis – new data to support methylation-based liquid biopsy

New study demonstrates enormous potential Earlier this month, we published a blog which highlighted ...

Methylomics – analysing DNA methylation signatures to diagnose cancer
Thomas Driver - June 9, 2021

Methylomics – analysing DNA methylation signatures to diagnose cancer

Traditional tissue biopsies are a vital aspect of current medical practices which help us diagnose ...

Diagnosing concussion: liquid biopsy is changing the game
Alex Galbraith - May 12, 2021

Diagnosing concussion: liquid biopsy is changing the game

Rugby, along with many other contact sports such as football, boxing and American football, has ...

What is the cancer microbiome?
Fay Allen - April 19, 2021

What is the cancer microbiome?

The “microbiome” is commonly associated with the gut microbiome, but recently the blood microbiome ...

Detecting progress: liquid biopsy in lung cancer
Alex Galbraith - March 8, 2021

Detecting progress: liquid biopsy in lung cancer

Lung cancer remained the leading cause of cancer death in 2020 with an estimated 1.8 million deaths ...

Go with the flow: the allure of the liquid biopsy
Frances Salisbury - December 2, 2020

Go with the flow: the allure of the liquid biopsy

Forward finds out how fresh technologies are providing a way to cut invasive procedures out of the ...

Liquid biopsies support precision medicine
Nick Sutcliffe - October 21, 2020

Liquid biopsies support precision medicine

The treatment of cancer patients with therapies that are specifically targeted to their cancer is a ...

Minimally invasive, maximum potential: liquid biopsy is redefining diagnosis
Anna Mudge - October 9, 2020

Minimally invasive, maximum potential: liquid biopsy is redefining diagnosis

Many of us will know someone who has undergone a biopsy during a medical diagnosis: we may even ...

Making the detection of cancer in liquid biopsies more sensitive
Nick Sutcliffe - September 22, 2020

Making the detection of cancer in liquid biopsies more sensitive

Besides being found within the nucleus and mitochondria of cells, DNA is also present in ...

The emergence of liquid biopsies as companion diagnostics
Jane Liu - September 2, 2020

The emergence of liquid biopsies as companion diagnostics

The development of liquid biopsies The term liquid biopsy refers to the use of different body ...

The evolutionary history of cancer - predicting the disease
Nick Sutcliffe - February 18, 2020

The evolutionary history of cancer - predicting the disease

Cells can acquire the mutations that drive the development of cancer many years before the patient ...

Will biomarkers come of age?
Anna Mudge - December 18, 2019

Will biomarkers come of age?

The world’s population is ageing. In 2018, for the first time in history, people aged 65 or above ...

Biomarkers and precision medicine
Anna Mudge - November 27, 2019

Biomarkers and precision medicine

A biomarker, an amalgamation of the term ‘biological marker’, is a measurable indicator of a ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy